Newsroom

Press Releases

 

AllianceRx Walgreens Prime one of only two specialty pharmacies to distribute Vyepti™, the first and only intravenous preventive treatment for migraine

Orlando, Fla. – May 19, 2020 – Lundbeck, a global pharmaceutical company specializing in brain diseases, has named AllianceRx Walgreens Prime one of only two specialty pharmacies to distribute its newest medication for the preventive treatment of migraine in adults. The medication, Vyepti™ (eptinezumab-jjmr), is the first and only intravenous preventive

Read More >

Media Contact

Adrienne Foley
Corporate Communications Manager
[email protected]

Connect with us 24/7